American Journal of Alzheimer's Disease and Other Dementias® (AJADD) is for and by professionals on the frontlines of Alzheimer's care, dementia, and clinical depression--especially physicians, nurses, psychiatrists, healthcare administrators, and other related healthcare specialists who deal with patients having dementias and families everyday. In every issue, you will find down-to-earth clinical information on
- Practical medical, psychiatric, and nursing issues such as assessment and management of problem behaviors, communication difficulties, dealing with delusions and other psychotic features, apathy, effects of physical activity, integrated treatment approaches, new and changing pharmacotherapies, orientation behaviors, and hospice use. AJADD also includes information on management of concurrent medical issues in the patient with dementia.
- New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. AJADD also provides information on the clinical features and management of non-Alzheimer's dementias.
- Psychosocial issues such as dealing with staff caregivers' distress, improving caregivers' communication skills, helping patients and families to deal with a diagnosis of Alzheimer's disease or another dementia, and patients' perceptions and preferences.
- Practice-oriented clinical research from the frontiers of neurology and genetics, including sleep-wake states, targeting glutamate excitotoxicity, cholesterol and apolipoprotein E, and other aspects of the underlying biology that causes the symptoms of dementia. AJADD also reports on the latest clinical trials that focus on medications for the symptoms of dementia and the disease process.
- Administrative and legal issues such as coding, consumer evaluation of adult day-care services, cost-effectiveness of special care units, dangerous wandering, end-stage dementia, informed consent, Medicare coverage for cognitively impaired residents, supervision of high-risk fall dementia patients, and vulnerable populations and avoidable hospitalizations.
By 2025, it is estimated that there will be about 34 million people in the world with some form of Alzheimer's disease or other dementia. To stay ahead of the latest research, clinical practices and procedures, and administrative issues, subscribe to American Journal of Alzheimer's Disease and Other Dementias® today!
This journal is a member of the Committee on Publication Ethics (COPE).
American Journal of Alzheimer's Disease and other Dementias® offers physicians, nurses, psychiatrists, nursing home and assisted living administrators, and other healthcare professionals who deal with patients with dementias and their families everyday, a multi-disciplinary, peer-reviewed international forum for original research, case studies, and media reviews on behavior management, brain research, caregiving, communication strategies, evaluation, heredity, long-term care, memory loss, pharmacotherapy, psychosocial issues, recreation and activity therapy, restraint-free care, special care units, and symptom management.
|Raymond Chuen-Chung Chang, PhD||The University of Hong Kong, Hong Kong, China|
|Cindy Chi Ching Pang||The University of Hong Kong, Hong Kong, China|
|Norman Abeles, PhD||Michigan State University, USA|
|Carmela Abraham, Phd||Boston University - School of Medicine, USA|
|Sally Albrecht, MS||President, Activities and Interventions in Dementia, Inc. (AID)|
|Donna L. Algase, PhD, RN, FAAN, FGSA||Director, Center on Frail and Vulnerable Elders|
|Gjumrakch Aliev, MD, PhD||University of Atlanta, USA|
|Myra Aud||Assistant Professor, Sinclair School of Nursing, University of Missouri--Columbia, USA|
|Francois Boller, MD, PhD||INSERM, France|
|Amy Renee Borenstein, PhD, MPH||Professor, Department of Epidemiology and Biostatistics|
|Heiko Braak, MD||Department of Anatomy|
|John C. S. Breitner, MD. MPH||Professor and Head, Division of Geriatric Psychiatry and Behavioral Sciences, USA|
|Linda Buettner, PhD||Co-Director, Southwest Florida Center for Positive Aging, USA|
|Maria Theresa Caserta, PhD, MD||Associate Professor of Psychiatry and Director of Adult Residency Training|
|Neelima B. Chauhan, PhD||University of Illinois, Chicago, IL, USA|
|Yuzhi Chen, PhD||Assistant Professor, Geriatrics|
|Bruce Alexander Citron, PhD||Molecular Medicine, Bay Pines VA, USA|
|Malka Cohen-Armon, DSc||Assistant Prof., Neufeld Cardiac Research Institute, Tel-Aviv University, Israel|
|John James Cotter, PhD||Virginia Commonwealth University, USA|
|Jose Ramon Criado, PhD||Clark Fellow in Neurophysiology, Adjunt Assistant Prof., Dept. of Neuropharmacology, USA|
|Jeffrey L. Cummings, MD||Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA|
|Neal E. Cutler, PhD||Prof. of Financial Gerontology|
|Stephen J. Cutler, PhD||University of Vermont, USA|
|Peter Davies, PhD||IFREMER, France|
|John Disterhoft, MD||Professor of Cell and Molecular Biology and Psychology|
|Jon Dobson, PhD||Prof. of Biophysics and Biomedical Engineering|
|David A. Drachman, MD||Prof. and Chair, Dept. of Neurology, USA|
|Tomasz Dziedzic, PhD, MD||Assistant in Dept. of Neurology|
|Piet Eikelenboom, MD||Professor of Neuropsychiatry|
|Carl Eisdorfer, PhD, MD||Prof. and Chairman, Dept. of Psychiatry and Behavioral Sciences, USA|
|Carol J. Farran, DNSc, RN, FAAN||Chair in Health and the Aging Process, College of Nursing|
|Lindsey A. Farrer, PhD||Professor of Neurology and Public Health, Chief of Genetics Unit|
|F. Richard Ferraro, PhD||University of North Dakota, USA|
|Maria E. Figueiredo-Pereira, PhD||Associate Prof., Dept. of Biological Sciences|
|Alan Foldi V.M.D, Ph.D.||PreProf., Dept. of Physiology and Biophysics, Nova Scotia, Canada|
|Pierluigi Gambetti, MD||Institute of Pathology|
|Cheng-Xin Gong, MD, MS||Head, Laboratory of Brain Metabolism|
|Iliana Gozes, PhD||Prof. of Clinical Biochemistry, Tel Aviv University, Israel|
|Steven Greenberg, MD, PhD||Neurologist|
|Xianlin Han, PhD||Assistant Professor of Medicine|
|Ying Han||Xuan Wu Hospital, Capital Medical University, China|
|Victor W. Henderson, MD, MS||Stanford University, USA|
|Kenneth W. Hepburn, PhD||Professor and Associate Dean for Research|
|Yeun-Shan Ho, PhD||The Hong Kong Polytechnic University, Hong Kong, China|
|Bradley T. Hyman, MD, PhD||Department of Neurology|
|Shannon E. Jarrott, PhD||Assistant Professor, Dept. Human Development|
|Henry Ka-Fung Mak, PhD||The University of Hong Kong, Hong Kong, China|
|Joanne Koenig-Coste, M.Ed||Alzheimer Consultant, USA|
|Christine R. Kovach, PhD, RN||Associate Professor|
|Daniel Kuhn, MSW||Education Director|
|Shupeng Li, PhD||Shenzhen Graduate School of Peking University, China|
|Mary Lucero||President, Geriatric Resources, Inc.|
|Colin L. Masters, MD||Prof. and Head, Dept. of Pathology|
|Richard Mayeux, MD, MSc||Director, Gertrude H. Sergievsky Professor of Neurology, Psychiatry and Epidemiology|
|Patrizia Mecocci, MD, PhD||Associate Prof.|
|Rita Moretti||Dept of Clinical Medicine and Neurology|
|Judith R. O'Jile, PhD||Assistant Professor and Director, Neuropsychology Lab., Division of Psychology, Dept of Psychiatry and Human Behavior|
|Paul Raia, PhD||Director of Patient Care and Family Support|
|Stephen A. Rappaport, MD|
|Barry Reisberg, MD||Aging and Dementia Research Center, New York, New York, USA|
|Gerard Schellenberg, PhD||Associate Director of Research|
|Dennis J. Selkoe, MD||Professor of Neurology and Neuroscience|
|Rebecca Sleeper, Pharm D||Assistant Professor of Pharmacy Practice, Geriatrics, Texas Tech University Health Sciences Center, School of Pharmacy, USA|
|Joan Swearer, MD||Department of Neurology|
|John Q. Trojanowski, MD, PhD||Pathology and Laboratory Medicine|
|Ian Trounce, PhD||Collie Senior Research Fellow|
|Magda Tsolaki, MD||Assistant Professor of Neurology|
|Holly A. Tuokko, PhD, Rpsych||Professor, Center on Aging|
|Christine Van Broeckhoven, MD||University of Antwerp, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, Belgium|
|Jianzhi Wang||Huangzhong University of Science and Technology, China|
|Bengt Winblad, MD, PhD||Professor, Dept. of Clinical Neuroscience and Family Medicine, Huddinge Hospital, Sweden|
|Xifei Yang||Shenzhen Center for Disease Control and Prevention, China|
|Ying Yang, PhD||Huazhong University of Science and Technology, China|
|Jeremy Brenton Yorgason, PhD||Prof, Gerentology Ctr, Health and Human Development, USA|
|Steve Zarit, PhD||The Pennsylvania State University, USA|
|Zaijun Zhang, PhD||Jinan University, China|
|Guo-qing Zheng||Wenzhou Medical College, China|
Manuscript Preparation and Submission
1. General Considerations
Manuscripts should be submitted to http://mc.manuscriptcentral.com/ajad
Files should be submitted in Microsoft Word and should include the following elements: complete author names, author contact information, author credentials and affiliations, acknowledgments, abstract (150 words or less), keywords, references, tables, illustrations, and legends. The format and style of the manuscript should follow the guidelines of AMA manual of style (10th ed.). There is no word limit or page count for manuscripts submitted to this journal.
American Journal of Alzheimer's Disease and Other Dementias® operates a conventional single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author. A minimum of two reviewers consider each manuscript.
For details of manuscript preparation not covered herein, please examine recent issues of the journal. American Journal of Alzheimer's Disease and Other Dementias® does not accept qualitative research, case reports, or systematic reviews for publication.
2. Submission Process
User Account – The Manuscript Central program asks authors to generate an author/reviewer account if one has not been created already. Authors are required to supply their first and last names, email addresses, and keywords chosen from a list of those used previously in the journal.
Title, Abstract, and Keywords – Authors first supply the manuscript title and an abstract. The title should be reasonably short and communicate the main idea of the research. The abstract should not be longer than 150 words and should substantively summarize the article. Five keywords to facilitate electronic access to this manuscript should be listed after the abstract.Given that researchers increasingly rely upon Google Scholar and other search engines, choice of appropriate keywords is imperative to encourage downloads and citations.
Tables and Figures - All figures and tables should be titled and numbered Tables should be placed at the end of the file, following text and references, with callouts for each in the text. Elements in tables should be separated by tabs, not cells or lines. High-resolution figures should be uploaded as separate electronic files, with callouts for each in the text. Acceptable file formats for figures include TIFF, EPS, and JPEG, and PDF Microsoft Application Files are acceptable for vector art (line art). (Please do not send glossies).
Authors are responsible for correctness and completeness of references.
For each text citation there must be a corresponding reference in the reference list and for each reference there must be a corresponding text citation. Cite references in consecutive order using superscript Arabic numbers. Each superscript must match one reference in the References list. Use commas to separate multiple citation numbers in text. Corresponding references should be listed in numeric order at the end of the document. Unpublished works and personal communications (oral, written, and electronic) should be cited parenthetically (and not on the reference list). Superscript numbers are placed outside periods and commas, and inside colons and semicolons. When more than 2 references are cited at a given place in the manuscript, use hyphens to join the first and last numbers of a closed series; use commas without space to separate other parts of a multiple citation.
Basic rules for the reference list are:
- The title “References” is centered at the top of a separate page at the end of the document.
Entries are preceded by their number and are given in numerical order.
The reference list should be single-spaced. Single-space between entries.
Do not use “et al.” in the Reference list at the end; names of all authors of a publication should be listed there.
References should be typed in the style adopted by the American Medical Association. For example:
Author(s) separated by commas. Title of Book. Place of publication: Publisher; year.
Goldberg L, Elliot DL. Exercise for Prevention and Treatment of Illness. Philadelphia, Pa: FA Davis Co; 1994.
Author(s), eds. Title of Book. Place of publication: Publisher; year.
Armitage JO, Antman KH, eds. High Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells. Baltimore, Md: Williams & Wilkins; 1995.
Chapter or article from a book
Author(s) of article. Title of article. In: Editor's name, ed. Title of Book. Place of publication: Publisher; Year: Chapter or page number.
Gamble VN. On becoming a physician: a dream not deferred. In: White EC, ed. The Black Women's Health Book: Speaking for Ourselves. Seattle, Wash: Seal Press; 1990:52-64.
They should be structured properly. Each table must have a clear and concise title. They should be numbered consecutively in the order in which they appear in the text. For each Table, there must be a corresponding citation in the text and for each Table citation here must be a corresponding Table.
They should be numbered consecutively in the order in which they appear in the text and must include figure captions. Figures will appear in the published article in the order in which they are numbered initially. The figure resolution should be 300dpi at the time of submission.
6. Ethical Guidelines
American Journal of Alzheimer's Disease and Other Dementias® requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declaration of conflicting interests
It is the policy of American Journal of Alzheimer's Disease and Other Dementias® to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here
Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
American Journal of Alzheimer's Disease and Other Dementias® conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
7. Permission Guidelines
Authors are solely responsible for obtaining all necessary permissions and for paying any associated fees. Permission must be granted in writing by the copyright holder and must accompany the submitted manuscript. Authors are responsible for the accuracy of facts, opinions, and interpretations expressed in the article.
All published materials are copyrighted by Sage Publications, Inc. Every lead author must sign an electronic contract before an article can be published.
Authors who would like to refine the use of English in their manuscripts might consider using Sage Language Services. This service is open to any authors who need assistance cleaning up their paper and are willing to pay professionals for help. Please note that using this service does not guarantee acceptance into the journal, but is intended a resource for editing, translating, figure and text formatting, and other manuscript preparation needs.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
For more details, please review the submission guidelines.
Inquiries may be directed to:
Cindy Chi Ching Pang